To sum up, SRSF1, HECW2, SRSF6, UBE2Z and PCF11 are implicated in the proliferation, apoptosis or metastasis of cancer cells and offer potential research avenues for use as diagnostic and prognostic biomarkers of HM management. This evidence concerns the gene HECW2 and cancer.